Cytochroma
Cytochroma provides preclinical drug developers with stem cell-derived liver models that predict drug safety and efficacy across genetically diverse populations. They use an ethnically diverse induced pluripotent stem cell (iPSC) library combined with automated cell manufacture and maturation workflows to produce mature hepatocytes for toxicity testing. Their platform pairs physiologically relevant cell models with rapid screening capabilities to identify safety signals and support lead selection. Cytochroma operates as a B2B service for biopharma and life science companies focused on de-risking compounds prior to clinical trials.
Cytochroma
Cytochroma provides preclinical drug developers with stem cell-derived liver models that predict drug safety and efficacy across genetically diverse populations. They use an ethnically diverse induced pluripotent stem cell (iPSC) library combined with automated cell manufacture and maturation workflows to produce mature hepatocytes for toxicity testing. Their platform pairs physiologically relevant cell models with rapid screening capabilities to identify safety signals and support lead selection. Cytochroma operates as a B2B service for biopharma and life science companies focused on de-risking compounds prior to clinical trials.